JPWO2020158890A1 - - Google Patents

Info

Publication number
JPWO2020158890A1
JPWO2020158890A1 JP2020568610A JP2020568610A JPWO2020158890A1 JP WO2020158890 A1 JPWO2020158890 A1 JP WO2020158890A1 JP 2020568610 A JP2020568610 A JP 2020568610A JP 2020568610 A JP2020568610 A JP 2020568610A JP WO2020158890 A1 JPWO2020158890 A1 JP WO2020158890A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020568610A
Other languages
Japanese (ja)
Other versions
JPWO2020158890A5 (https=
JP7406192B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020158890A1 publication Critical patent/JPWO2020158890A1/ja
Publication of JPWO2020158890A5 publication Critical patent/JPWO2020158890A5/ja
Application granted granted Critical
Publication of JP7406192B2 publication Critical patent/JP7406192B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2020568610A 2019-01-31 2020-01-30 線維症治療薬 Active JP7406192B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019015226 2019-01-31
JP2019015226 2019-01-31
PCT/JP2020/003522 WO2020158890A1 (ja) 2019-01-31 2020-01-30 線維症治療薬

Publications (3)

Publication Number Publication Date
JPWO2020158890A1 true JPWO2020158890A1 (https=) 2020-08-06
JPWO2020158890A5 JPWO2020158890A5 (https=) 2023-06-14
JP7406192B2 JP7406192B2 (ja) 2023-12-27

Family

ID=71841860

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020568610A Active JP7406192B2 (ja) 2019-01-31 2020-01-30 線維症治療薬

Country Status (3)

Country Link
US (1) US12138251B2 (https=)
JP (1) JP7406192B2 (https=)
WO (1) WO2020158890A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023176879A1 (ja) * 2022-03-16 2023-09-21 国立大学法人 熊本大学 生活習慣病の予防又は治療に使用するための医薬組成物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HOSONO, TETSUJI ET AL.: "Antiviral activities against herpes simplex virus type 1 by HPH derivatives and their structure acti", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 18, JPN6020006623, 2008, pages 371 - 374, ISSN: 0005210939 *
LUONG, VU HUY ET AL.: "Blockade of TGF-β/Smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosi", ARTHRITIS RESEARCH & THERAPY, vol. Vol.20:46, JPN6020006621, 2018, pages 1 - 13, ISSN: 0005210937 *
RIEDER, FLORIAN AND FIOCCHI, CLAUDIO: "Intestinal fibrosis in inflammatory bowel disease Current knowledge and future perspectives", JOURNAL OF CROHN'S AND COLITIS, vol. 2, JPN6020006622, 2008, pages 279 - 290, XP025692409, ISSN: 0005210938, DOI: 10.1016/j.crohns.2008.05.009 *

Also Published As

Publication number Publication date
WO2020158890A1 (ja) 2020-08-06
US20220096448A1 (en) 2022-03-31
US12138251B2 (en) 2024-11-12
JP7406192B2 (ja) 2023-12-27

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021017637A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
BR112021017728A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112019016142A2 (https=)
BR112019016138A2 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20210730

AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20211207

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211214

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230124

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230606

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231205

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231205

R150 Certificate of patent or registration of utility model

Ref document number: 7406192

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150